View of ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer

Return to Article Details ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer Download Download PDF